These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3160660)

  • 1. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
    Ames P; DesJardins D; Pier GB
    Infect Immun; 1985 Aug; 49(2):281-5. PubMed ID: 3160660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
    Schreiber JR; Pier GB; Grout M; Nixon K; Patawaran M
    J Infect Dis; 1991 Sep; 164(3):507-14. PubMed ID: 1831226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
    Baltimore RS; Mitchell M
    J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
    Pier GB; Elcock ME
    J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide.
    Garner CV; DesJardins D; Pier GB
    Infect Immun; 1990 Jun; 58(6):1835-42. PubMed ID: 2140341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Pier GB; Matthews WJ; Eardley DD
    J Infect Dis; 1983 Mar; 147(3):494-503. PubMed ID: 6220094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.
    Ramphal R; Pier GB
    Infect Immun; 1985 Jan; 47(1):1-4. PubMed ID: 3155514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
    Pier GB; DesJardin D; Grout M; Garner C; Bennett SE; Pekoe G; Fuller SA; Thornton MO; Harkonen WS; Miller HC
    Infect Immun; 1994 Sep; 62(9):3972-9. PubMed ID: 8063415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.
    Kashef N; Behzadian-Nejad Q; Najar-Peerayeh S; Mousavi-Hosseini K; Moazzeni M; Djavid GE
    J Med Microbiol; 2006 Oct; 55(Pt 10):1441-1446. PubMed ID: 17005795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2006 Dec; 13(12):1333-42. PubMed ID: 17021246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. II. In vitro bactericidal and opsonophagocytic studies with specific antiserum.
    Lieberman MM; Frank WJ; Brady AV
    J Surg Res; 1988 Mar; 44(3):251-8. PubMed ID: 3125389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.